Annette Meeson - Search Results

Year	Number of Results
2003	1
2004	2
2007	2
2010	2
2011	2
2012	2
2013	5
2014	4
2016	2
2017	1
2018	2
2019	2
2020	1
2021	1
2022	5
2023	2
2024	0

1

Nanocarrier-Based Targeted Therapies for Myocardial Infarction.

George TA, Hsu CC, Meeson A, Lundy DJ. George TA, et al. Among authors: meeson a. Pharmaceutics. 2022 Apr 25;14(5):930. doi: 10.3390/pharmaceutics14050930. Pharmaceutics. 2022. PMID: 35631516 Free PMC article. Review.

2

TGF-β, to target or not to target; to prevent thyroid cancer progression?

Karnik I, Sutherland R, Elson J, Aspinall S, Meeson A. Karnik I, et al. Among authors: meeson a. Biochim Biophys Acta Rev Cancer. 2022 Jul;1877(4):188752. doi: 10.1016/j.bbcan.2022.188752. Epub 2022 Jun 18. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35728736 Review.

3

Stem cell biology and therapeutic applications.

Garry DJ, Masino AM, Meeson AP, Martin CM. Garry DJ, et al. Among authors: meeson ap. Curr Opin Nephrol Hypertens. 2003 Jul;12(4):447-54. doi: 10.1097/00041552-200307000-00014. Curr Opin Nephrol Hypertens. 2003. PMID: 12815342 Review.

4

Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis.

Sutherland R, Meeson A, Lowes S. Sutherland R, et al. Among authors: meeson a. Cancer Metastasis Rev. 2020 Sep;39(3):919-932. doi: 10.1007/s10555-020-09879-6. Cancer Metastasis Rev. 2020. PMID: 32388639 Free PMC article. Review.

5

Correction: del Molino del Barrio et al. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12. Int. J. Mol. Sci. 2018, 19, 3592.

Del Molino Del Barrio I, Wilkins GC, Meeson A, Ali S, Kirby JA. Del Molino Del Barrio I, et al. Among authors: meeson a. Int J Mol Sci. 2023 Dec 4;24(23):17108. doi: 10.3390/ijms242317108. Int J Mol Sci. 2023. PMID: 38069447 Free PMC article.

6

Limbal side population cells: a future treatment for limbal stem cell deficiency.

Shaharuddin B, Ahmad S, Ali S, Meeson A. Shaharuddin B, et al. Among authors: meeson a. Regen Med. 2013 May;8(3):319-31. doi: 10.2217/rme.13.18. Regen Med. 2013. PMID: 23627826 Review.

7

Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.

Mallini P, Lennard T, Kirby J, Meeson A. Mallini P, et al. Among authors: meeson a. Cancer Treat Rev. 2014 Apr;40(3):341-8. doi: 10.1016/j.ctrv.2013.09.008. Epub 2013 Sep 15. Cancer Treat Rev. 2014. PMID: 24090504 Review.

8

The role of FOXP3 in the development and metastatic spread of breast cancer.

Douglass S, Ali S, Meeson AP, Browell D, Kirby JA. Douglass S, et al. Among authors: meeson ap. Cancer Metastasis Rev. 2012 Dec;31(3-4):843-54. doi: 10.1007/s10555-012-9395-3. Cancer Metastasis Rev. 2012. PMID: 22833279 Review.

9

Concise review: immunological properties of ocular surface and importance of limbal stem cells for transplantation.

Shaharuddin B, Ahmad S, Meeson A, Ali S. Shaharuddin B, et al. Among authors: meeson a. Stem Cells Transl Med. 2013 Aug;2(8):614-24. doi: 10.5966/sctm.2012-0143. Epub 2013 Jul 1. Stem Cells Transl Med. 2013. PMID: 23817133 Free PMC article. Review.

10

Porous scaffold for mesenchymal cell encapsulation and exosome-based therapy of ischemic diseases.

Czosseck A, Chen MM, Nguyen H, Meeson A, Hsu CC, Chen CC, George TA, Ruan SC, Cheng YY, Lin PJ, Hsieh PCH, Lundy DJ. Czosseck A, et al. Among authors: meeson a. J Control Release. 2022 Dec;352:879-892. doi: 10.1016/j.jconrel.2022.10.057. Epub 2022 Nov 14. J Control Release. 2022. PMID: 36370875 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year